Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy

被引:30
作者
Fischmann, Arne [1 ]
Gloor, Monika [2 ]
Fasler, Susanne [2 ]
Haas, Tanja [2 ]
Wetzel, Rachele Rodoni
Bieri, Oliver [2 ]
Wetzel, Stephan [3 ]
Heinimann, Karl [4 ]
Scheffler, Klaus [2 ]
Fischer, Dirk [5 ,6 ]
机构
[1] Univ Basel Hosp, Inst Radiol, Dept Neuroradiol, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Inst Radiol, Dept Radiol Phys, CH-4031 Basel, Switzerland
[3] Hirslanden Klin Zurich, Swiss Neuro Inst, Dept Neuroradiol, Zurich, Switzerland
[4] Univ Basel Childrens Hosp, Dept Med Genet, Basel, Switzerland
[5] Univ Childrens Hosp, Dept Neuropaediat, Basel, Switzerland
[6] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
MRI; Motor function measurement; Outcome measure; Muscle; Oculopharyngeal muscular dystrophy; OPMD; MUSCLE DEGENERATION; DISEASES;
D O I
10.1007/s00415-011-5937-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Oculopharyngeal muscular dystrophy (OPMD) is a progressive skeletal muscle dystrophy characterized by ptosis, dysphagia, and upper and lower extremity weakness. We examined eight genetically confirmed OPMD patients to detect a MRI pattern and correlate muscle involvement, with validated clinical evaluation methods. Physical assessment was performed using the Motor Function Measurement (MFM) scale. We imaged the lower extremities on a 1.5 T scanner. Fatty replacement was graded on a 4-point visual scale. We found prominent affection of the adductor and hamstring muscles in the thigh, and soleus and gastrocnemius muscles in the lower leg. The MFM assessment showed relative mild clinical impairment, mostly affecting standing and transfers, while distal motor capacity was hardly affected. We observed a high (negative) correlation between the validated clinical scores and our visual imaging scores suggesting that quantitative and more objective muscle MRI might serve as outcome measure for clinical trials in muscular dystrophies.
引用
收藏
页码:1333 / 1340
页数:8
相关论文
共 21 条
[1]  
BARBEAU A, 1969, PROGR NEUROOPHTHALMO, V2, P3
[2]   A motor function measure scale for neuromuscular diseases.: Construction and validation study [J].
Bérard, C ;
Payan, C ;
Hodgkinson, L ;
Fermanian, J .
NEUROMUSCULAR DISORDERS, 2005, 15 (07) :463-470
[3]   Oculopharyngeal muscular dystrophy: clinical and CT findings [J].
Bilgen, C ;
Bilgen, IG ;
Sener, RN .
COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2001, 25 (06) :527-529
[4]   Oculopharyngeal muscular dystrophy [J].
Brais, B ;
Rouleau, GA ;
Bouchard, JP ;
Fardeau, M ;
Tomé, FMS .
SEMINARS IN NEUROLOGY, 1999, 19 (01) :59-66
[5]   THE OCULOPHARYNGEAL MUSCULAR-DYSTROPHY LOCUS MAPS TO THE REGION OF THE CARDIAC ALPHA-MYOSIN AND BETA-MYOSIN HEAVY-CHAIN GENES ON CHROMOSOME 14Q11.2-Q13 [J].
BRAIS, B ;
XIE, YG ;
SANSON, M ;
MORGAN, K ;
WEISSENBACH, J ;
KORCZYN, AD ;
BLUMEN, SC ;
FARDEAU, M ;
TOME, FMS ;
BOUCHARD, JP ;
ROULEAU, GA .
HUMAN MOLECULAR GENETICS, 1995, 4 (03) :429-434
[6]   Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy [J].
Brais, B ;
Bouchard, JP ;
Xie, YG ;
Rochefort, DL ;
Chrétien, N ;
Tomé, FMS ;
Lafrenière, RG ;
Rommens, JM ;
Uyama, E ;
Nohira, O ;
Blumen, S ;
Korcyn, AD ;
Heutink, P ;
Mathieu, J ;
Duranceau, A ;
Codère, F ;
Fardeau, M ;
Rouleau, GA .
NATURE GENETICS, 1998, 18 (02) :164-167
[7]   Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy [J].
Fan, XP ;
Rouleau, GA .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2003, 30 (01) :8-14
[8]   Oculopharyngeal muscular dystrophy in France [J].
Fardeau, M ;
Tome, FMS .
NEUROMUSCULAR DISORDERS, 1997, 7 :S30-S33
[9]   Distinct muscle imaging patterns in myofibrillar myopathies [J].
Fischer, D. ;
Kley, R. A. ;
Strach, K. ;
Meyer, C. ;
Sommer, T. ;
Eger, K. ;
Rolfs, A. ;
Meyer, W. ;
Pou, A. ;
Pradas, J. ;
Heyer, C. M. ;
Grossmann, A. ;
Huebner, A. ;
Kress, W. ;
Reimann, J. ;
Schroeder, R. ;
Eymard, B. ;
Fardeau, M. ;
Udd, B. ;
Goldfarb, L. ;
Vorgerd, M. ;
Olive, M. .
NEUROLOGY, 2008, 71 (10) :758-765
[10]   Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs [J].
Fischer, D ;
Walter, MC ;
Kesper, K ;
Petersen, JA ;
Aurino, S ;
Nigro, V ;
Kubisch, C ;
Meindl, T ;
Lochmüller, H ;
Wilhelm, K ;
Urbach, H ;
Schröder, R .
JOURNAL OF NEUROLOGY, 2005, 252 (05) :538-547